To compare the relative MATR3 expression levels in a small panel of human breast cancer cell lines with basal-like/triple-negative breast cancer (BLBC/TNBC) properties, we performed western blotting with a specific antibody against MATR3. This evidence concerns the gene MATR3 and breast carcinoma.